Not recruiting
Acute myeloid leukaemia+1
Not recruitingStudy on Molidustat and Ivosidenib for Adults with Relapsed or Refractory IDH1-Mutated Acute Myeloid Leukemia or Myelodysplastic Syndrome
Registered drugNo placebo
Study on Molidustat and Ivosidenib for Adults with Relapsed or Refractory IDH1-Mutated Acute Myeloid Leukemia or Myelodysplastic Syndrome
Registered drugNo placebo
- Disease:Acute myeloid leukaemiaMyelodysplastic syndrome
- Substances:IvosidenibMolidustat Sodium
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Ivosidenib